Kwality Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kwality Pharmaceuticals Ltd. on BSE

Load latest

Kwality Pharmaceuticals Ltd.

23 Aug 2024

806.70

7.65%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Clarification On Price Movement

BSE India

Clarification on Price Movement is attached

pdf

Kwality Pharmaceuticals Ltd.

22 Aug 2024

806.70

7.65%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Clarification sought from Kwality Pharmaceuticals Ltd

BSE India

The Exchange has sought clarification from Kwality Pharmaceuticals Ltd on August 22, 2024, with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Kwality Pharmaceuticals Ltd.

13 Aug 2024

806.70

7.65%

Company Update

Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of results for q.e. 30-06-2024 attached herewith

pdf

Kwality Pharmaceuticals Ltd.

12 Aug 2024

806.70

7.65%

Result

Kwality Pharmaceuticals Ltd - 539997 - Rectification Of Typographical Error And Submission Of Revised Financial Results …

BSE India

Revised Results for Q. E. 30-06-2024 are attached herewith after correction of minor typographical error. This will have no effect on the figures of financial results of the company declared for q.e. 30-06-2024.

pdf

Kwality Pharmaceuticals Ltd.

10 Aug 2024

806.70

7.65%

Result

Kwality Pharmaceuticals Ltd - 539997 - Submission Of Standalone And Consolidated Un-Audited Financial Results For The …

BSE India

Results for Q.E. 30.06.2024 are attached

pdf

Kwality Pharmaceuticals Ltd.

10 Aug 2024

806.70

7.65%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Submission Of Standalone And Consolidated Un-Audited …

BSE India

We are submitting herewith the standalone and consolidated un-audited financial results under Regulation 33 of the Securities and Exchange board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended as on 30.06.2024 along with the Auditors limited review reports thereon.

pdf

Kwality Pharmaceuticals Ltd.

02 Aug 2024

806.70

7.65%

Board Meeting

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited …

BSE India

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2024 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended on 30th June, 2024.

pdf